By Forum Staff
On Monday, at the federal courthouse in Brooklyn, two indictments were unsealed charging India-based companies Raxuter Chemicals and Athos Chemicals Pvt. Ltd. and Bhavesh Lathiya, a founder and senior executive of Raxuter Chemicals, with criminal conspiracies to distribute and import fentanyl precursor chemicals to the United States. Lathiya was arrested on Jan. 4, 2025 in New York City.
Raxuter Chemicals and Lathiya are charged with conspiracy to distribute and import a listed chemical, distribution and importation of a listed chemical knowing it would be used to manufacture fentanyl, smuggling and other related offenses. Athos Chemicals is charged with similar offenses, including conspiracy to distribute and import a listed chemical and distribution and importation of a listed chemical.
As alleged in the indictments and court filings, the defendants supplied precursor chemicals to the United States and Mexico, among other places, knowing they would be used to manufacture fentanyl. They also sent their chemical products to the United States and Mexico using international mail and package carriers. The chemicals distributed by the defendants included all the materials necessary to manufacture fentanyl via the most common methods or pathways. To prevent detection and interception of chemical products at the borders, the defendants employed deceptive and fraudulent practices, such as mislabeling packages, falsifying customs forms, and making false declarations at border crossings.
For example, on or about June 29, 2024, a package shipped by Raxuter Chemicals was delivered to an address in the Eastern District of New York. The package had a false manifest that listed its contents as Vitamin C. In truth, the contents were a List I chemical, 1-boc-4-piperidone, an unlawfully imported fentanyl precursor.
On or about Oct. 2, 2024 and Oct. 15, 2024, Lathiya appeared on a video call to discuss sale of fentanyl precursor chemicals with a Homeland Security Investigations undercover officer. After being told by the undercover officer that his “clients in Mexico were very happy with the quality of what you sent me” and with “the yield they got of the final product,” Lathiya agreed to sell 20 kilograms 1-boc-4-piperidone, which is a List I chemical used in fentanyl synthesis. Lathiya also proposed mislabeling the chemical as an antacid. The undercover officer replied and asked if it would be easier to ship the product to Mexico, stating “This is a very controversial product … Because like you said it’s banned and in Mexico I think it could be easier but there’s so much pressure on them because of fentanyl.” On or about Nov. 23, 2024, Raxuter Chemicals and Lathiya shipped approximately 20 kilograms of 1-boc-4-piperidone to the Eastern District of New York. The package was mislabeled as an antacid.
In addition, on or about Feb. 20, 2024, Athos Chemicals agreed to sell 100 kilograms of 1-boc-4-piperidone to a known drug trafficker in Mexico who was making fentanyl in association with a drug trafficking organization.
Mexican drug trafficking organizations, including but not limited to the Sinaloa Cartel, have increasingly availed themselves of the fentanyl precursors developed and distributed by companies like the defendants. The chemicals provided by the defendant companies have enabled such cartels and other drug trafficking organizations to produce fentanyl in clandestine laboratories in Mexico on a massive scale for subsequent distribution in the United States and elsewhere.
If convicted of all the charges, Lathiya faces up to 53 years in prison.
